Indazoles used to treat estrogen receptor beta mediated disorders
US7960563B2 · kind B2 · utility
33Cited by
1References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 5, 2008 |
| Grant date | Jun 14, 2011 |
| Priority date | — |
| Expiry date | Mar 5, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to novel indazole derivatives having pharmacological activity, processes for their preparation, compositions containing them and uses of these compounds in the treatment of estrogen receptor beta mediated diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.